ORIGINAL RESEARCH ARTICLE | Nov. 2, 2026
Factors Associated with Placenta Accreta Spectrum among Women Presenting with Antepartum Haemorrhage: A Retrospective Study at a Tertiary Hospital in Bangladesh
Fatama Tul Tanzina Chowdhury, Mabruka Faizah, Farzana Khaleda Alin, Fahim Ara Khanam Jenny, Vikarunnessa Sonia
Page no 338-344 |
https://doi.org/10.36348/sijog.2026.v09i11.001
Background: Placenta accreta spectrum (PAS) is an important cause of severe maternal morbidity, particularly among women presenting with antepartum haemorrhage (APH). Early identification of women at increased risk may facilitate timely referral and appropriate obstetric planning. This study aimed to identify predictors of PAS among women presenting with APH. Methods: This retrospective observational study was conducted in the Department of Obstetrics and Gynaecology, Sylhet Women's Medical College Hospital, Sylhet, Bangladesh, from January to December 2025. A total of 110 women presenting with APH after 28 weeks of gestation admitted to the Department during the study period were included. Results: Among 110 women, 25 (22.7%) had PAS. Significant associations were observed with maternal age ≥35 years, multiparity, ≥2 previous cesarean deliveries, previous uterine surgery, previous dilatation and curettage, placenta previa, anterior placenta, recurrent APH, and multiple ultrasonographic features suggestive of PAS. On multivariable analysis, ≥2 previous cesarean deliveries (adjusted OR=5.76, 95% CI: 2.01–16.53), placenta previa (adjusted OR=6.92, 95% CI: 2.41–19.86), and ≥2 suggestive ultrasonographic features (adjusted OR=18.64, 95% CI: 5.02–69.19) were independent predictors of PAS. Cesarean hysterectomy, blood transfusion, ICU admission, preterm delivery, and low birth weight were significantly more common among women with PAS. Conclusion: PAS was relatively common among women presenting with APH, particularly those with previous cesarean delivery, placenta previa, and characteristic ultrasonographic findings. Early identification of these risk factors may help improve antenatal risk stratification and obstetric preparedness.
ORIGINAL RESEARCH ARTICLE | Nov. 2, 2026
Discordance Between Clinicopathological and Molecular Risk Classification in Endometrial Carcinoma: A Prospective Observational Study
Shakila Laizo, Rifat Ara, Susmita Sarker, Shahana Parvin, Sadia Jabeen
Page no 345-352 |
https://doi.org/10.36348/sijog.2026.v09i11.002
Background: Endometrial carcinoma is commonly managed using clinicopathological risk stratification to guide adjuvant treatment. However, p53 and mismatch repair (MMR) status may identify biological risks not captured by conventional classifications. Local evidence regarding discordance between clinicopathological and molecular risk profiles remains limited. This study aimed to assess this discordance and to describe treatment allocation and one-year outcomes among patients with molecular abnormalities. Methods: This prospective observational study was conducted at the National Institute of Cancer Research and Hospital, Dhaka, from October 2021 to May 2023 and included 42 women with endometrial carcinoma who underwent definitive surgery. Risk was assigned by the ESGO/ESTRO/ESP 2021 consensus, p53 and MMR proteins were assessed by immunohistochemistry and patients were followed for one year. Fisher's exact test was used for outcome comparisons. Results: Conventional classification identified 17 low-risk (40.5%) and 18 high-risk (42.9%) patients, with seven in intermediate categories. Abnormal p53 expression was found in five patients (11.9%) and MMR deficiency in 16 (38.1%). Among the 17 low-risk patients, one (5.88%) had abnormal p53 and seven (41.17%) were MMR deficient; among the 18 high-risk patients, four (22.2%) had abnormal p53 and five (27.78%) were MMR deficient. No low-risk patient with a molecular abnormality received adjuvant treatment or progressed. Freedom from progression was 60.0% with abnormal p53 versus 97.3% with normal p53 (p=0.001) and 93.8% versus 92.3% for MMR-deficient and MMR-retained tumours (p=0.414). Conclusion: Molecular abnormalities occurred in conventionally low-risk endometrial carcinoma, indicating that clinicopathological classification alone does not capture molecular risk. Combined assessment may refine risk stratification, pending larger confirmatory studies.
Perinatal depression represents a significant public health concern across the Gulf Cooperation Council (GCC) region; however, psychometric validation of screening tools in these culturally distinct populations remains inadequately synthesised. Prevalence estimates vary substantially depending on screening thresholds, while cultural factors such as stigma, somatic symptom expression, and family-centred decision-making influence symptom presentation and help-seeking behaviour. This review aimed to identify and critically appraise the diagnostic accuracy of perinatal depression screening tools validated across all six GCC member states (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates). A comprehensive search was conducted across five electronic databases (PubMed, Ovid MEDLINE, Embase, Global Health, and APA PsycINFO) without language restrictions, supplemented by manual reference screening. Eligible studies were required to validate screening tools against reference standards in GCC perinatal populations. Methodological quality was assessed using the QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies 2) framework, and findings were synthesised narratively. Only three validation studies were identified, all evaluating the Arabic Edinburgh Postnatal Depression Scale (EPDS) in the United Arab Emirates, Qatar, and Oman. Reported sensitivity and specificity were broadly acceptable; however, all studies exhibited moderate to high risk of bias, and no validation evidence was identified for Bahrain, Kuwait, or Saudi Arabia. Whilst the Arabic EPDS currently represents the most empirically supported screening tool in the region, the evidence base remains limited in scope, methodological rigour, and geographical coverage. Further research should prioritise robust validation studies in GCC countries and the development of culturally grounded screening approaches.
ORIGINAL RESEARCH ARTICLE | Nov. 14, 2026
Menstrual Bleeding Patterns in Women with Thyroid Dysfunction and Abnormal Uterine Bleeding at a Tertiary Care Hospital in Bangladesh
Sharmin Haque*, Mohammad Mostafizur Rahman, Mursheda Akhter, Anjuman Rubin Lucky, Jasmin Ferdous
Page no 376-383 |
https://doi.org/10.36348/sijog.2026.v09i11.004
Background: Thyroid dysfunction can disturb ovulation and endometrial bleeding, yet local data on menstrual bleeding patterns among women with abnormal uterine bleeding (AUB) remain limited. Objective: To evaluate menstrual bleeding patterns among women with thyroid dysfunction presenting with AUB at a tertiary care hospital in Bangladesh. Methods: This hospital-based observational cross-sectional study was conducted in the Department of Obstetrics and Gynaecology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, from October 2015 to March 2016. Fifty women presenting with AUB were included through consecutive sampling. All participants underwent clinical evaluation and thyroid function testing and were classified as euthyroid, hypothyroid or hyperthyroid. Data were analysed using SPSS version 16.0. Results: The mean age of the participants was 34.57 ± 9.27 years, and 52.0% were aged 36–45 years. Most participants were urban residents (58.0%) and housewives (56.0%). Thyroid dysfunction was present in 13 women (26.0%), including hypothyroidism in 9 (18.0%) and hyperthyroidism in 4 (8.0%), while 37 (74.0%) were euthyroid. Among women with thyroid dysfunction, menorrhagia was the most common bleeding pattern (61.53%), followed by polymenorrhoea (23.07%), polymenorrhagia (7.69%) and oligomenorrhoea (7.69%). Menorrhagia was observed in 66.7% of hypothyroid women, whereas menorrhagia and polymenorrhoea each accounted for 50.0% of hyperthyroid women. Abdominal pain (76.0%) and nausea or vomiting (68.0%) were the most common associated symptoms. Conclusion: Thyroid dysfunction was present in approximately one-fourth of women presenting with AUB, with hypothyroidism being more common than hyperthyroidism. Menorrhagia was the predominant bleeding pattern among women with thyroid dysfunction. Thyroid function assessment may be considered as part of the evaluation of women presenting with AUB.
ORIGINAL RESEARCH ARTICLE | Nov. 14, 2026
Prevalence and Factors Associated with Postpartum Urinary Symptoms among Women Attending Two Hospitals in Shendi, Sudan: A Hospital-Based Cross-Sectional Study
Sami Hummeda Elnour Hummeda, Israa Al Tayeb, Ibrahim Bakhit Yousif Elemam, Ghanem Mohammed Mahjaf*
Page no 384-388 |
https://doi.org/10.36348/sijog.2026.v09i11.005
Background: Postpartum urinary symptoms are common and may adversely affect women’s physical, psychological, and social well-being. This study assessed the prevalence and factors associated with postpartum urinary symptoms among women attending two hospitals in Shendi, Sudan. Methods: A hospital-based descriptive cross-sectional study was conducted at Al Mak Nemir University Hospital and Shendi Teaching Hospital from July 2024 to January 2025. The study included 98 women attending the hospitals within the first six weeks after childbirth who fulfilled the study inclusion criteria. Data were collected using an interviewer-administered questionnaire after obtaining informed consent and were analysed using SPSS version 26. Results: Postpartum urinary symptoms were reported by 34 of 98 women (34.7%). Among the 34 symptomatic women, the most frequently reported symptoms were urgency (13/34, 38.2%), frequency (9/34, 26.5%), and nocturia (6/34, 17.6%). In the bivariate analysis, statistically significant associations were reported for age (p=0.029), educational level (p=0.027), occupation (p=0.024), residence (p=0.013), circumcision (p=0.001), body mass index (BMI; p=0.025), mode of delivery (p=0.028), duration of labour (p=0.018), episiotomy (p=0.014), early removal of urinary catheterisation (p=0.001), and postpartum complications (p=0.031). Parity was not significantly associated with symptoms (p=0.066). Conclusion: Approximately one-third of the women in this hospital-based sample reported urinary symptoms during the first six weeks postpartum. Several sociodemographic and obstetric characteristics showed statistically significant associations. Larger studies using clearly defined urinary outcomes and adjusted analyses are needed to confirm these findings.